Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia

Neuropharmacology

Volumn 62, Issue 5-6, 2012, Pages 1928-1934

  Zhang, Xiang Yang ^a,b,c,d   Zhou, Dong Feng ^a   Shen, Yu Cun ^a   Zhang, Pei Yan ^d   Zhang, Wu Fang ^a   Liang, Jun ^a   Chen, Da Chun ^d   Xiu, Mei Hong ^d   Kosten, Therese A ^b   Kosten, Thomas R ^b  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INSTITUTE OF PSYCHOLOGY   (China)

^d BEIJING HUILONGGUAN HOSPITAL   (China)

Author keywords

Antipsychotic treatment; Free radical; Oxidative stress; Schizophrenia

Indexed keywords

HALOPERIDOL; NITRIC OXIDE; PLACEBO; RISPERIDONE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; RISPERIDONE; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE;

EID: 84862808118     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.12.014     Document Type: Article

References (58)

1. O. Akyol, H. Herken, E. Uz, E. Fadillioglu, S. Unal, S. Sogut, H. Ozyurt, and H.A. Savas The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance Prog. Neuro-psychopharmacol. Biol. Psychiatry 26 2002 995 1005 (Pubitemid 35245568)
2. O. Akyol, S.S. Zoroglu, F. Armutcu, S. Sahin, and A. Gurel Nitric oxide as a physiopathological factor in neuropsychiatric disorders In Vivo 18 3 2004 377 390 (Pubitemid 39069754)
3. H. Baba, T. Suzuki, H. Arai, and P.C. Emson Expression of nNOS and soluble guanylate cyclase in schizophrenic brain Neuroreport 15 2004 677 680 (Pubitemid 38457159)
4. L. Ben Othmen, A. Mechri, C. Fendri, M. Bost, G. Chazot, L. Gaha, and A. Kerkeni Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 155 159
5. H.G. Bernstein, B. Bogerts, and G. Keilhoff The many faces of nitric oxide in schizophrenia. A review Schizophr. Res. 78 2005 69 86 (Pubitemid 41188326)
6. B.K.Y. Bitanihirwe, and T.U.W. Woo Oxidative stress in schizophrenia: an integrated approach Neurosci. Biobehav. Rev. 35 3 2011 878 893
7. J.L. Cadet, and A.S. Perumal Chronic treatment with Prolixin causes oxidative stress in rat brain Biol. Psychiatry 28 1990 738 740 (Pubitemid 20333635)
8. I. Das, N.S. Khan, B.K. Puri, S.R. Sooranna, J.D. Belleroche, and S.R. Hirsch Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain Biochem. Biophys. Res. Commun. 212 1995 375 380
9. I. Das, C.N. Ramchand, A. Gliddon, and S.R. Hirsch Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia Neuropsychobiology 37 1998 65 67 (Pubitemid 28143016)
10. A. Dietrich-Muszalska, and B. Kontek Lipid peroxidation in patients with schizophrenia Psychiatry Clin. Neurosci. 64 2010 469 475
11. C. Fendri, A. Mechri, G. Khiari, A. Othman, A. Kerkeni, and L. Gaha Oxidative stress involvement in schizophrenia pathophysiology: a review Encephale 32 2006 244 252 (Pubitemid 43670234)
12. R.N. Fiddler Collaborative study of modified AOAC method of analysis for nitrite in meat and meat products J. Assoc. Off. Anal. Chem. 60 1977 594 599
13. C.S. Gama, M. Salvador, A.C. Andreazza, F. Kapczinski, and P. Silva Belmonte-de-Abreu Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 512 515
14. F.X. Guix, I. Uribesalgo, M. Coma, and J. Munoz The physiology and pathophysiology of nitric oxide in the brain Prog. Neurobiol. 76 2005 126 152 (Pubitemid 41242885)
15. H. Herken, E. Uz, H. Ozyurt, S. Sogut, O. Virit, and O. Akyol Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia Mol. Psychiatry 6 2001 66 73 (Pubitemid 32096067)
16. T.L. Huang, C.W. Liou, and T.K. Lin Serum thiobarbituric acid-reactive substances and free thiol levels in schizophrenia patients: effects of antipsychotic drugs Psychiatry Res. 177 1-2 2010 18 21
17. J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine Arch. Gen. Psychiatry 45 1988 789 796
18. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276 (Pubitemid 18039085)
19. M. Kuloglu, B. Ustundag, M. Atmaca, H. Canatan, A.E. Tezcan, and N. Cinkilinc Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder Cell Biochem. Funct. 20 2 2002 171 175
20. M. Kunz, C.S. Gama, A.C. Andreazza, M. Salvador, K.M. Ceresér, F.A. Gomes, P.S. Belmonte-de-Abreu, M. Berk, and F. Kapczinski Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1677 1681
21. Y.S. Lau, E. Petroske, G.E. Meredith, and J.Q. Wang Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats Neuropharmacology 45 2003 986 994 (Pubitemid 37297924)
22. B.H. Lee, and Y.K. Kim Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls Schizophr. Res. 104 2008 36 43
23. J.B. Lohr Oxygen radicals and neuropsychiatric illness. Some speculations Arch. Gen. Psychiatry 48 1991 1097 1106
24. J.B. Lohr, and J.A. Browning Free radical involvement in neuropsychiatric illnesses Psychopharmacol. Bull. 31 1995 159 165
25. J.B. Lohr, R. Kuczenski, and A.B. Niculescu Oxidative mechanisms and tardive dyskinesia CNS Drugs 17 2003 47 62 (Pubitemid 36044348)
26. S.P. Mahadik, and S. Mukherjee Free radical pathology and antioxidant defense in schizophrenia: a review Schizophr. Res. 19 1996 1 17 (Pubitemid 26133208)
27. S. Mukherjee, S.P. Mahadik, R. Scheefer, E.E. Correnti, and H. Kelkar Impaired antioxidant defense at the onset of psychosis Schizophr. Res. 19 1996 19 26 (Pubitemid 26133209)
28. A. Nel, and B.H. Harvey Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine Behav. Pharmacol. 14 2003 251 255 (Pubitemid 36735159)
29. F. Ng, M. Berk, O. Dean, and A.I. Bush Oxidative stress in psychiatric disorders: evidence base and therapeutic implications Int. J. Neuropsychopharmacol. 11 2008 851 876
30. M. Padurariu, A. Ciobica, I. Dobrin, and C. Stefanescu Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics Neurosci. Lett. 479 2010 317 320
31. V. Parikh, M.M. Khan, and S.P. Mahadik Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain J. Psychiatr. Res. 37 2003 43 51 (Pubitemid 35449770)
32. M. Raffa, A. Mechri, L.B. Othman, C. Fendri, L. Gaha, and A. Kerkeni Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1178 1183
33. J. Ramirez, R. Garnica, M.C. Boll, S. Montes, and C. Rios Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study Schizophr. Res. 68 2004 357 361 (Pubitemid 38526156)
34. P.K. Ranjekar, A. Hinge, M.V. Hegde, M. Ghate, A. Kale, S. Sitasawad, U.V. Wagh, V.B. Debsikdar, and S.P. Mahadik Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res. 121 2003 109 122 (Pubitemid 37500981)
35. R.D. Reddy, M. Keshavan, and J.K. Yao Reduced plasma antioxidants in first-episode patients with schizophrenia Schizophr. Res. 62 2003 205 212 (Pubitemid 36773929)
36. R.D. Reddy, M.P. Sahebarao, S. Mukherjee, and J.N. Murthy Enzymes of the antioxidant defense system in chronic schizophrenic patients Biol. Psychiatry 30 1991 409 412
37. R. Reddy, S.P. Mahadik, and S. Mukherjee Neuroleptic effects on the enzymes of the antioxidant defense system in manic and schizophrenic patients Biol. Psychiatry 31 1992 248
38. R.D. Reddy, and J.K. Yao Free radical pathology in schizophrenia: a review Prostaglandins Leukot. Essent. Fatty Acids 55 1996 33 43 (Pubitemid 26321116)
39. A. Reinke, M.R. Martins, M.S. Lima, J.C. Moreira, F. Dal-Pizzol, and J. Quevedo Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain Neurosci. Lett. 372 2004 157 160 (Pubitemid 39505248)
40. A. Sarandol, S. Kirli, C. Akkaya, A. Altin, M. Demirci, and E. Sarandol Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 1164 1169 (Pubitemid 47081301)
41. A. Schotte, P.E. Janssen, W. Gommeren, W.H. Luyten, P. Van Bompel, L.S. Lesage, K. De Loore, and J.E. Levsen Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology 124 1996 57 73 (Pubitemid 26112775)
42. N. Srivastava, M.K. Barthwal, P.K. Dalal, A.K. Agarwal, D. Nag, R.C. Srimal, P.K. Seth, and M. Dikshit Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients Psychopharmacology 158 2001 140 145 (Pubitemid 33020832)
43. E. Suzuki, T. Nakaki, M. Nakamura, and H. Miyaoka Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia J. Psychiatry Neurosci. 28 2003 288 292 (Pubitemid 37153436)
44. F. Taneli, S. Pirildar, F. Akdeniz, B.S. Uyanik, and Z. Ari Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia Arch. Med. Res. 35 2004 401 405 (Pubitemid 40018180)
45. F.I. Tarazi, K. Zhang, and R.J. Baldessarini Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain Nitric Oxide 7 2002 297 300 (Pubitemid 35365675)
46. M. Yanik, H. Vural, A. Kocyigit, H. Tutkun, S.S. Zoroglu, H. Herken, H.A. Sava, A. Köylü, and O. Akyol Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 47 2 2003 61 65 (Pubitemid 36469841)
47. J.K. Yao, R. Reddy, L.G. McElhinny, and D.P. van Kammen Effects of haloperidol on antioxidant defense system enzymes in schizophrenia J. Psychiatr. Res. 32 1998 385 391 (Pubitemid 28491244)
48. J.K. Yao, R.D. Reddy, and D.P. van Kammen Abnormal age related changes of plasma antioxidant proteins in schizophrenia Psychiatry Res. 97 2000 137 151 (Pubitemid 32126553)
49. J.K. Yao, R.D. Reddy, and D.P. van Kammen Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications CNS Drugs 15 2001 287 310 (Pubitemid 32337052)
50. J.K. Yao, C.G. Sistilli, and D.P. van Kammen Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia Prostaglandins Leukot. Essent. Fatty Acids 69 6 2003 429 436 (Pubitemid 37464053)
51. J.K. Yao, S. Leonard, and R.D. Reddy Increased nitric oxide radicals in postmortem brain from patients with schizophrenia Schizophr. Bull. 30 4 2004 923 934 (Pubitemid 40469526)
52. O. Yermolaieva, N. Brot, H. Weissbach, S.H. Heinemann, and T. Hoshi Reactive oxygen species and nitric oxide mediate plasticity of neuronal calcium signaling Proc. Natl. Acad. Sci. U.S.A. 97 1 2000 448 453 (Pubitemid 30055851)
53. X.Y. Zhang, D.F. Zhou, L.Y. Cao, P.Y. Zhang, G.Y. Wu, and Y.C. Shen Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study Int. Clin. Psychopharmacol. 16 6 2001 325 330
54. X.Y. Zhang, D.F. Zhou, L.Y. Cao, D.C. Chen, F.Y. Zhu, and G.Y. Wu Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements Schizophr. Res. 62 2003 245 250 (Pubitemid 36773933)
55. X.Y. Zhang, D.F. Zhou, L.Y. Cao, P.Y. Zhang, G.Y. Wu, and Y.C. Shen The effect of risperidone treatment on superoxide dismutase in schizophrenia J. Clin. Psychopharmacol. 23 2003 128 131 (Pubitemid 36368789)
56. X.Y. Zhang, D.F. Zhou, L.Y. Cao, P. Zhang, and G.Y. Wu Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms Psychiatry Res. 117 2003 85 88 (Pubitemid 36173777)
57. X.Y. Zhang, Y.L. Tan, L.Y. Cao, G.Y. Wu, Q. Xu, Y. Shen, and D.F. Zhou Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics Schizophr. Res. 81 2006 291 300 (Pubitemid 43107705)
58. S.S. Zoroglu, H. Herken, M. Yürekli, E. Uz, H. Tutkun, H.A. Sava, C. Bagci, M.E. Ozen, B. Cengiz, E.A. Cakmak, M.I. Dogru, and O. Akyol The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia J. Psychiatr. Res. 36 2002 309 315 (Pubitemid 34764055)